Cannabinoids for use in the treatment of neurodegenerative diseases or disorders
View Patent ↗The present invention relates to cannabinoids for use in the prevention or treatment of neurodegenerative diseases or disorders. Preferably the cannabinoids are cannabichromene (CBC) cannabidivarin (CBDV) and/or cannabidivarin acid (CBDVA). More preferably the neurodegenerative disease or disorder to be prevented or treated is Alzheimer's disease.
1. A method for treating neurodegenerative diseases or disorders comprising administering to a subject in need thereof a therapeutically effective amount of cannabinoids cannabidivarin (CBDV) and/or cannabidivarin acid (CBDVA), wherein the CBDV and/or CBDVA are isolated or purified.
2. The method of claim 1 , wherein the cannabinoid is CBDV.
3. The method of claim 1 , wherein the cannabinoid is CBDVA.
4. The method of claim 1 , wherein the neurodegenerative disease or disorder is selected from the group consisting of: Alzheimer's disease; Parkinson's disease; amyotrophic lateral sclerosis; and Huntington's disease.
5. The method of claim 4 , wherein the neurodegenerative disease or disorder to be prevented or treated is Alzheimer's disease.
6. The method of claim 1 , wherein the cannabinoid/s are administered in a daily dose effective to prevent or treat neurodegenerative diseases or disorders.
7. The method of claim 6 , wherein the effective daily dose of cannabinoid/s is between 5 mg and 1000 mg.
8. The method of claim 7 , wherein the effective daily dose of cannabinoid/s is between 10 mg and 50 mg.
9. The method of claim 1 , further comprising administering the cannabinoid/s in combination with one or more other medicinal substances.
10. The method of claim 1 , wherein the cannabinoid/s are in the form of a botanical drug substance (BDS).